Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes (Q62105671)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes |
clinical trial |
Statements
A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control (English)
0 references
August 2005
0 references
August 2006
0 references
1,440
0 references